Treatments for complications of tracheal sleeve resection for papillary thyroid carcinoma with tracheal invasion

Lin, Sheng; Huang, Hai; Liu, Xuekui; Li, Q.; Yang, Ankui; Zhang, Quan; Z, Guo; Chen, Y.

doi:10.1016/j.ejso.2013.12.008

Cited by 22 publications

(28 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Lin et al reported two anastomotic dehiscence over 19 patients (11%) explaining this complication as result of a not tension-free anastomosis (16). Furthermore, Piazza et al, in their series of 27 patients, detected an anastomotic dehiscence in 11% of cases (14).…”

Section: Anastomotic Dehiscencementioning

confidence: 98%

“…The bilateral vocal cord palsy due to recurrent laryngeal nerve injury occurs about in 10% of cases and it can be managed performing a partial CO 2 laser cordectomy or a tracheostomy (10,15,16). Although the tracheostomy allows an immediate and effectiveness management of bilateral vocal cord paralysis, it is not accepted by patients as a longterm solution also when associated with the use of T-tube (10,11).…”

Section: Airway Stenosismentioning

confidence: 99%

See 1 more Smart Citation

Complications from tracheal resection for thyroid carcinoma

Rotolo¹,

Cattoni²,

Imperatori³

2017

Gland Surg.

View full text Add to dashboard Cite

Section: Anastomotic Dehiscencementioning

confidence: 98%

Section: Airway Stenosismentioning

confidence: 99%

Complications from tracheal resection for thyroid carcinoma

Rotolo¹,

Cattoni²,

Imperatori³

2017

Gland Surg.

View full text Add to dashboard Cite

“…There were 64 individual case reports and 96 case series (consisting of more than one case). Of the 96 case series, 17 series contained enough details to extract individual patient data; these 110 patients were analyzed with the individual case reports (8)(9)(10)(11)(12)(13)(14)(15)(16)(17)(18)(19)(20)(21)(22)(23)(24). Forty-five case series reported exclusively on tracheal invasion by thyroid cancer (Table S1).…”

Section: Quantity Of Evidencementioning

confidence: 99%

Secondary tracheal tumors: a systematic review

Madariaga¹,

Gaissert²

2018

Ann. Cardiothorac. Surg.

View full text Add to dashboard Cite

Background: Secondary tracheal tumors arise from mural invasion by primary tumors in adjacent organs, metastatic lymph nodes or blood-born metastasis from distant sites. This systematic review aims to assess the presentation, management options, and clinical outcomes of these uncommon non-tracheal malignancies.Methods: Electronic searches of the MEDLINE database were performed to identify case series and individual case reports of tracheal invasion by primary non-tracheal tumors or metastatic disease. AllEnglish-language studies with available abstracts or articles containing primary data were included.Results: From 1978 to 2017, a total of 160 case reports or case series identified 2,242 patients with invasion of the trachea by tumors of adjacent organs (n=1,853) or by metastatic lymph nodes or hematogenous spread (n=389). Common primary sites of origin were thyroid, esophagus, and lung, and the most common presentation was metachronous (range of interval: 0 to 564 months) with dyspnea, neck mass, voice change and/or hemoptysis. A majority of patients in case reports (77.9%) and case series (66.0%) underwent resection and the most common reported operation was segmental tracheal resection. Fewer patients underwent bronchoscopic intervention (21.7%) and radiation was used in 32.2% of patients. Complications after bronchoscopic treatment included bleeding, granulation tissue, and retained secretions, while anastomotic leak, unplanned tracheostomy, and new recurrent laryngeal nerve paralysis were observed after surgical resection. The rate of 30-day mortality was low (0.01-1.80%). Median survival was higher in patients with thyroid malignancy and in patients who underwent surgical management. Follow-up time ranged from 0.03 to 183 months. Conclusions:Patients with tracheal invasion by metastatic or primary non-tracheal malignancies should be assessed for symptoms, tumor grade, tumor recurrence and concurrent metastases to decide on optimal surgical, bronchoscopic or noninterventional therapy. Clinical experience suggests that palliative endoscopic intervention for tracheal obstruction by metastasis-bearing lymph nodes is underreported.Keywords: Endotracheal metastasis; secondary tracheal tumors; systematic review Submitted Nov 24, 2017. Accepted for publication Dec 21, 2017Dec 21, . doi: 10.21037/acs.2018 View this article at: http://dx.doi.org/10.21037/acs.2018.02.01 Systematic Review IntroductionSecondary tracheal tumors are defined as tumors in, but not of the trachea and comprise a wide spectrum of tumor histologies and stages. There are no populationbased data for these tumors, and in clinical practice these lesions are probably more common than primary neoplasms. A thoracic surgeon probably encounters tracheal obstruction by metastatic lymph nodes more often than invasion by adjacent primary tumors. Since natural history and prognosis are related to the tumor of origin, their management and prognosis may differ considerably from primary tracheal neoplasms; a correct diagnosis with attribution to the origi...

show abstract

“…Of 40 cases by Nakao et al, anastomotic failure occurred in 4 (10%) and 3 of these died (in two, due to the perforation of the artery and mediastinitis in one) [267]. Lin et al reported 2 cases (10%) of anastomotic failure among 19 patients that underwent tracheal reconstruction [268].…”

Section: Summary Of Literaturementioning

confidence: 99%

The revised clinical practice guidelines on the management of thyroid tumors by the Japan Associations of Endocrine Surgeons: Core questions and recommendations for treatments of thyroid cancer

Onoda²,

2020

View full text Add to dashboard Cite

The Japan Associations of Endocrine Surgeons has developed the revised version of the Clinical Practice Guidelines for Thyroid Tumors. This article describes the guidelines translated into English for the 35 clinical questions relevant to the therapeutic management of thyroid cancers. The objective of the guidelines is to improve health-related outcomes in patients with thyroid tumors by enabling users to make their practice evidence-based and by minimizing any variations in clinical practice due to gaps in evidential knowledge among physicians. The guidelines give representative flowcharts on the management of papillary, follicular, medullary, and anaplastic thyroid carcinoma, along with recommendations for clinical questions by presenting evidence on the relevant outcomes including benefits, risks, and health conditions from patients' perspective. Therapeutic actions were recommended or not recommended either strongly (◎◎◎ or XXX) based on good evidence ( )/good expert consensus (+++), or weakly (◎, ◎◎ or X, XX) based on poor evidence ( )/poor expert consensus (+ or ++). Only 10 of the 51 recommendations given in the guidelines were supported by good evidence, whereas 35 were supported by good expert consensus. While implementing the current guidelines would be of help to achieve the objective, we need further clinical research to make our shared decision making to be more evidence-based.

show abstract

Treatments for complications of tracheal sleeve resection for papillary thyroid carcinoma with tracheal invasion

Cited by 22 publications

References 22 publications

Complications from tracheal resection for thyroid carcinoma

Complications from tracheal resection for thyroid carcinoma

Secondary tracheal tumors: a systematic review

The revised clinical practice guidelines on the management of thyroid tumors by the Japan Associations of Endocrine Surgeons: Core questions and recommendations for treatments of thyroid cancer

Contact Info

Product

Resources

About